🇺🇸 FDA

Drug profile · INN

cephradine

VELOSEF

approved
US status
approved
Patents linked
8
News articles
0

Quick answer

cephradine (VELOSEF) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN cephradine
Brand VELOSEF
Route INJECTION
Formulation FOR SUSPENSION
Originator Teva Pharma GmbH

Related patents

Search patents →

  1. US 12383566

    Inhibition of SLC transporter activity or expression to attenuate anthracycline-induced cardiotoxicity

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12365659

    Non-polyamine based polyamine transport inhibitors and their use in the treatment of human cancers

    Expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12350510

    Magnetic microwires for energy-transporting biomedical applications

    Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12336835

    Neuromodulation to target glucose transporter and/or incretin pathways

    Expires Mon Jun 19 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12329780

    Acute and chronic mitochondrial electron transport chain dysfunction treatments and graphenic materials for use thereof

    Expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12291508

    Hydrazide containing nuclear transport modulators and uses thereof

    Expires Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12247973

    Plasma membrane citrate transporter for use in the diagnosis and treatment of cancer

    Expires Mon Mar 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12173306

    Codon-optimized reduced-size ATP7A CDNA and uses for treatment of copper transport disorders

    Expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is cephradine?

cephradine (VELOSEF) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for cephradine?

VELOSEF is a marketed brand name for cephradine. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of cephradine?

cephradine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.